KRAS c.433T>G ;(p.S145A)

Variant ID: 12-25378565-A-C

NM_004985.3(KRAS):c.433T>G;(p.S145A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma.

Trends In Biochemical Sciences
Yin, Lei-Miao LM; Ulloa, Luis L; Yang, Yong-Qing YQ
Publication Date: 2019-10

Variant appearance in text: KRAS: S145A
PubMed Link: 31256982
Variant Present in the following documents:
  • Main text
View BVdb publication page



Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.

Journal Of Experimental & Clinical Cancer Research : Cr
Sun, Yan Y; Peng, Wenfang W; He, Weiwei W; Luo, Man M; Chang, Guilin G; Shen, Jiping J; Zhao, Xiaoping X; Hu, Yu Y
Publication Date: 2018-07-24

Variant appearance in text: KRAS: S145A
PubMed Link: 30041673
Variant Present in the following documents:
  • Main text
  • 13046_2018_Article_818.pdf
View BVdb publication page



Pan-urologic cancer genomic subtypes that transcend tissue of origin.

Nature Communications
Chen, Fengju F; Zhang, Yiqun Y; Bossé, Dominick D; Lalani, Aly-Khan A AA; Hakimi, A Ari AA; Hsieh, James J JJ; Choueiri, Toni K TK; Gibbons, Don L DL; Ittmann, Michael M; Creighton, Chad J CJ
Publication Date: 2017-08-04

Variant appearance in text: KRAS: 433T>G
PubMed Link: 28775315
Variant Present in the following documents:
  • 41467_2017_289_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page